Integrase Strand Transfer Inhibitors and Weight Gain in Children and Youth With Perinatal Human Immunodeficiency Virus in the DC Cohort
Author(s) -
Wei Li Adeline Koay,
Sahera DirajlalFargo,
Matthew E. Levy,
Paige Kulie,
Anne K. Monroe,
Amanda D. Castel,
Natella Rakhmanina,
Lawrence J. D’Angelo,
Michael Kharfen,
Michael Serlin,
Princy Kumar,
Aria Bamdad,
Tsedenia Bezabeh,
Pamela K. Burrows,
Susan Reamer,
Alla Sapozhnikova,
Marinella Temprosa,
Naji Younes,
Morgan Byrne,
Alan E. Greenberg,
Maria Jaurretche,
James Peterson,
Lindsey Powers Happ,
Brittany Wilbourn,
Yan Ma,
Hana Akselrod,
Ronald D Wilcox,
Sohail Rana,
Michael A. Horberg,
Ricardo Fernández,
Annick Hebou,
Carl W. Dieffenbach,
Henry Masur,
José Bordón,
Gebeyehu Teferi,
Debra Benator,
Marı́a Elena Ruiz,
Stephen Abbott
Publication year - 2021
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofab308
Subject(s) - medicine , integrase , confidence interval , cohort , human immunodeficiency virus (hiv) , retrospective cohort study , integrase inhibitor , pediatrics , virology , viral load , antiretroviral therapy
We conducted a retrospective analysis of 38 children and youth with human immunodeficiency virus (aged 0–19 years) in the United States and report an increased rate of change of BMI-for-age z score after initiating integrase strand transfer inhibitors (+0.19 z score units/year [95% confidence interval, .01–.37]; P = .036) for a median follow-up of 527.5 days.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom